| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2019 | Barer Sol J | Director | Buy | 111,000 | $8.98 | $997,013.10 | +2,246% | |
| May 20, 2019 | De Notaristefani Carlo | Executive VP Global Operations | Sale+OE | 16,070 | $11.42 | $183,519.40 | -32.4% | |
| May 16, 2019 | De Notaristefani Carlo | Executive VP Global Operations | Sale+OE | 629 | $11.76 | $7,397.04 | -3.2% | |
| Mar 18, 2019 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 320 | $16.64 | $5,326.27 | -3.4% | |
| Mar 18, 2019 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,358 | $16.43 | $38,741.94 | -44.2% | |
| Mar 18, 2019 | McClellan Michael James | EVP, Chief Financial Officer | Sale+OE | 230 | $16.63 | $3,823.77 | -1.8% | |
| Mar 18, 2019 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 1,179 | $16.63 | $19,600.99 | -45.9% | |
| Mar 18, 2019 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 943 | $16.63 | $15,677.47 | -100% | |
| Mar 18, 2019 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 356 | $16.63 | $5,918.54 | -1.0% | |
| Mar 18, 2019 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 632 | $16.63 | $10,507.06 | -6.5% |